Peptide RL-QN15 Regulates Functions of Epidermal Stem Cells to Accelerate Skin Wound Regeneration via the FZD8/β-Catenin Axis
Yuansheng Li , Qiuye Jia , Naixin Liu , Saige Yin , Junyuan Wang , Yujing Ding , Yuliu Yang , Ying Peng , Zeqiong Ru , Shaoyang Zhang , Bu'er Qi , Jun Sun , Li He , Ying Wang , Kun Guo , Xinwang Yang
Exploration ›› 2026, Vol. 6 ›› Issue (3) : 20240090
The pursuit of developing groundbreaking pro-regenerative therapies to expedite skin wound healing persists as a formidable challenge. Peptide RL-QN15, emerges as a highly promising candidate for the first pro-regenerative drug derived from amphibian skin, offering a glimmer of hope for innovative healing treatments. Yet, there is an urgent need for intensified research efforts to propel RL-QN15 from a molecular entity to a viable drug candidate, particularly in unraveling the mechanisms underlying its exceptional pro-healing efficacy. In the current research, our results revealed that RL-QN15 significantly enhanced the proliferation, migration, stemness, and epithelial-to-mesenchymal transition of human epidermal stem cells (hESCs) through direct binding to the membrane frizzled 8 (FZD8) receptor. This interaction triggers the downstream Wnt/β-catenin signaling pathway, leading to the up-regulation of target genes MYC and CCND1. Furthermore, RL-QN15 augmented the expression and secretion of matrix metalloproteinase-3, which degrades E-cadherin and activates the Wnt/β-catenin pathway, thereby amplifying RL-QN15's regulatory effects on hESCs. In summary, our findings have demonstrated that RL-QN15 modulated the functions of ESCs to accelerate skin wound regeneration via the FZD8/β-catenin axis. This research not only advances peptide RL-QN15 from a molecular entity to a drug candidate by shedding light on the mechanisms involved with regulation of ESCs functions, but also presents compelling evidence implicating FZD8 as a novel therapeutic target for skin wound regeneration.
epidermal stem cells / FZD8 receptor / RL-QN15 / skin wound healing / Wnt/β-catenin signaling pathway
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
2025 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |